{
  "meta": {
    "title": "49_Alcoholic_And_Infectious_Liver_Disease",
    "url": "https://brainandscalpel.vercel.app/49-alcoholic-and-infectious-liver-disease-3c42e433.html",
    "scrapedAt": "2025-11-30T12:33:48.084Z"
  },
  "questions": [
    {
      "text": "A 50-year-old man who developed myocardial infarction 3 days ago now presents with jaundice. Lab investigations done are given below. Which region of the liver lobule is most likely affected here?<div class='question-desc-html'><p>Bilirubin: 3 mg/dL</p>\n<p>ALT: 1250 IU/L</p>\n<p>AST: 1050 IU/L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Zone 1"
        },
        {
          "id": 2,
          "text": "Zone 2"
        },
        {
          "id": 3,
          "text": "Zone 3"
        },
        {
          "id": 4,
          "text": "Both zone 1 and 2"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\"><span class=\"s1\">The given clinical scenario is suggestive of<strong> acute hepatocellular injury</strong> due to ischemia.<strong> Zone 3 </strong>(<strong>centrilobular</strong> zone)&nbsp;of the liver is most <strong>susceptible</strong> for <strong>ischemia</strong> because this zone is the farthest from the blood supply.</span></p>\n<p class=\"p1\"><span class=\"s1\">On the basis of blood flow, liver parenchyma can be divided into three zones. Z</span>one 1 is closest to the blood supply and zone 3 is the farthest. They are:</p>\n<ul>\n<li class=\"p1\"><span class=\"s1\">Zone 1 - Periportal (around portal triad)</span></li>\n<li class=\"p1\"><span class=\"s1\">Zone 2 - Midzonal parenchyma</span></li>\n<li class=\"p1\"><span class=\"s1\">Zone 3 - Centrilobular (around hepatic vein)</span></li>\n</ul>\n<p class=\"p1\">A schematic diagram showing the hepatic lobule indicating the direction of blood flow and the zones of decreasing oxygenation is given below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/27353f2ec8d848c592a7d89d9a1ba455x1280x1316.JPEG\" alt=\"Explanation Image\"><p>Note: Zone most susceptible to toxin damage is zone 1.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6635",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions are least likely to develop centrilobular necrosis of liver?",
      "choices": [
        {
          "id": 1,
          "text": "Myocardial infarction"
        },
        {
          "id": 2,
          "text": "Acetaminophen toxicity"
        },
        {
          "id": 3,
          "text": "Yellow fever"
        },
        {
          "id": 4,
          "text": "Cardiac failure"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Centrilobular necrosis is not seen in yellow fever. In<strong> yellow fever</strong>, swelling and necrosis of hepatocytes are seen in the <strong>midzone </strong>of the liver lobule.</p>\n<p>Conditions causing<strong> tissue injury</strong> in the different zones of liver:</p>\n<ul>\n<li><strong>Centrilobular </strong>(Zone 3)\n<ul>\n<li>Chronic venous congestion&nbsp;(cardiac failure)</li>\n<li>Acetaminophen toxicity</li>\n<li>Budd Chiari syndrome</li>\n<li>Ischemia&nbsp;&nbsp;</li>\n<li>Alcoholic hepatitis</li>\n</ul>\n</li>\n<li><strong>Midzonal </strong>(Zone 2)\n<ul>\n<li>&nbsp;Yellow fever</li>\n</ul>\n</li>\n<li><strong>Periportal </strong>(Zone 1)\n<ul>\n<li>Viral hepatitis</li>\n</ul>\n</li>\n</ul>\n<p>A schematic diagram showing the hepatic lobule indicating the direction of blood flow and the zones of decreasing oxygenation is given below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/311a93e490524386a830ff96eea80dcex1280x1316.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5986",
      "difficulty": "medium"
    },
    {
      "text": "A chronic alcoholic developed cirrhosis of the liver. Which is the principal cell type involved in scar deposition in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatocytes"
        },
        {
          "id": 2,
          "text": "Hepatic stellate cells"
        },
        {
          "id": 3,
          "text": "Sinusoidal endothelial cells"
        },
        {
          "id": 4,
          "text": "Kupffer cells"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The principal cell type involved in <strong>scar</strong> deposition in<strong> cirrhosis</strong> of the liver is&nbsp;the <strong>hepatic stellate cell </strong>or Ito cell.</p>\n<p>Hepatic stellate cells deposit primarily <strong>type I </strong>and<strong> type III</strong> <strong>collagen </strong>in the lobule and cause fibrosis. In their quiescent form, these cells&nbsp;store&nbsp;<strong>lipids </strong>and<strong> vitamin A</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6015",
      "difficulty": "easy"
    },
    {
      "text": "Histopathological examination of liver biopsy reveals steatosis. Which of the following conditions is least likely to cause this change?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatitis B infection"
        },
        {
          "id": 2,
          "text": "Hepatitis C infection"
        },
        {
          "id": 3,
          "text": "Wilson's disease"
        },
        {
          "id": 4,
          "text": "Protein malnutrition"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Steatosis or fatty change of liver is not seen in hepatitis B infections.</p>\n<p><strong><span class=\"st\">Steatosis</span></strong><span class=\"st\">&nbsp;is the abnormal <strong>accumulation</strong> of <strong>triglycerides</strong> within a cell due to impaired lipid metabolism.&nbsp;</span>In the liver,<strong>&nbsp;pathological steatosis</strong> is defined as fatty change involving<strong> &gt;5%</strong> of hepatocytes. In the histologic sections, they appear as&nbsp;<strong>empty vacuoles </strong>within the hepatocyte cytoplasm.</p>\n<p><strong>Hepatitis C&nbsp;</strong>genotype 3 is reported to cause<strong> periportal steatosis.</strong>&nbsp;It is due to its association with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD).</p>\n<p>In <strong>Wilson's disease</strong>, there is focal hepatocyte necrosis and steatosis due to toxic injury by the excess copper.</p>\n<p>In <strong>protein malnutrition</strong>, fatty liver results from the reduced synthesis of the carrier protein component of lipoproteins.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6086",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following conditions causes macrovesicular steatosis of liver?",
      "choices": [
        {
          "id": 1,
          "text": "Reye syndrome"
        },
        {
          "id": 2,
          "text": "Obesity"
        },
        {
          "id": 3,
          "text": "Fatty liver of pregnancy"
        },
        {
          "id": 4,
          "text": "Valproate hepatotoxicity"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Macrovesicular</strong> fatty liver (steatosis) is seen in<strong> obesity</strong>.</p>\n<p><strong>Macrovesicular</strong> steatosis is characterized by a<strong> single, large</strong> vacuole of fat that fills up the hepatocyte and displaces the nucleus to the periphery. Causes include:</p>\n<ul>\n<li>Late alcoholic liver disease</li>\n<li>Obesity</li>\n<li>Protein-energy malnutrition</li>\n<li>Non-alcohlic steatohepatitis (NASH)</li>\n<li>Chronic hepatitis C</li>\n</ul>\n<p><strong>Microvesicular</strong> steatosis is characterized by small <strong>intracytoplasmic</strong> fat vacuoles, which accumulate in the cell.¬†Causes¬†include:</p>\n<ul>\n<li><strong>Acute fatty liver of pregnancy</strong></li>\n<li><strong>Reye syndrome</strong></li>\n<li>Early alcoholic liver disease</li>\n<li><strong>Drugs</strong> and toxins¬†</li>\n</ul>\n<p>The image given below shows macrovesicular and microvesicular steatosis of liver:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d5e6c15838974f7a87aef9bc1fbbfbf7x1280x1942.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6088",
      "difficulty": "medium"
    },
    {
      "text": "A 4-year-old girl, with a history of URTI, now presents with severe vomiting, lethargy, and altered mental status. You are suspecting Reye's syndrome. Which of the following liver biopsy findings will confirm your diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Centrizonal haemorrhagic necrosis"
        },
        {
          "id": 2,
          "text": "Marked microvesicular steatosis"
        },
        {
          "id": 3,
          "text": "Portal tract edema and perisinusoidal fibrosis"
        },
        {
          "id": 4,
          "text": "Cirrhosis and periportal eosinophilic inclusion bodies"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The&nbsp;liver biopsy in <strong>Reye's syndrome</strong> will show marked <strong>microvesicular steatosis</strong>.</p>\n<p>Reye's syndrome is an acute illness, encountered exclusively in<strong> children</strong> &lt;15 years. Its onset usually follows upper respiratory tract infections. The actual cause is unknown, although<strong> viral agents</strong> and <strong>salicylates</strong> (aspirin) have been implicated.</p>\n<p>Pathogenesis behind this condition is generalized <strong>mitochondrial dysfunction</strong> with structural and functional alterations of mitochondria in the&nbsp;liver, brain,&nbsp;and muscle. Liver is enlarged but jaundice is absent or minimum. It is characterized by clinical features such as:</p>\n<ul>\n<li>Vomiting</li>\n<li>Signs of progressive CNS damage</li>\n<li>Signs of hepatic injury</li>\n<li>Hypoglycemia</li>\n</ul>\n<p>Extensive accumulation of <strong>fat droplets </strong>within<strong> hepatocytes</strong> (microvesicular steatosis)<strong>&nbsp;</strong>can be seen in histopathology.&nbsp;Extra-hepatic changes include fatty changes of renal tubular cells, cerebral edema, and neuronal degeneration of the&nbsp;brain.</p>\n<p>The image given below shows microvesicular steatosis of liver.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4803f28a1bc5483692049453c8e99144x1280x952.JPEG\" alt=\"Explanation Image\"><p>Note: Aspirin is generally contraindicated in children, except in the treatment of Kawasaki disease and juvenile idiopathic arthritis.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5156",
      "difficulty": "medium"
    },
    {
      "text": "Histopathological examination of liver biopsy in a patient with jaundice shows the following finding. Which of the following conditions is least likely in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Wilson's disease"
        },
        {
          "id": 2,
          "text": "Primary biliary cholangitis"
        },
        {
          "id": 3,
          "text": "Primary sclerosing cholangitis"
        },
        {
          "id": 4,
          "text": "Indian childhood cirrhosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The marked structure in the image is<strong> Mallory hyaline body </strong>which&nbsp;is not seen in primary sclerosing cholangitis. In this condition, onion skin fibrosis is seen.</p>\n<p>Mallory hyaline bodies (<strong>Mallory&ndash;Denk bodies</strong>)&nbsp;are usually present as clumped, amorphous, eosinophilic material in ballooned hepatocytes. They are made up of&nbsp;<strong>cytokeratin 8</strong>&nbsp;and&nbsp;<strong>cytokeratin 18.</strong>&nbsp;They have a&nbsp;twisted rope-like&nbsp;appearance. On trichrome stain, they appear green/dark brown.&nbsp;They are seen in:&nbsp; &nbsp; &nbsp; &nbsp;</p>\n<div class=\"page\" title=\"Page 862\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Alcoholic liver disease</li>\n<li>Non-alcoholic fatty liver disease</li>\n<li>Wilson's disease</li>\n<li>Hepatocellular carcinoma</li>\n<li>Alpha-1 antitrypsin deficiency</li>\n<li>Primary biliary cholangitis (formerly called primary biliary cirrhosis)</li>\n<li>Indian childhood cirrhosis</li>\n</ul>\n<p>The image given below shows Mallory hyaline bodies.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f2cc149fb520481b841b0138a2020e93x1280x1539.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3d60c8ea13bc4cb18e4e7f6b0eb7da7ex1280x1539.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mallory Bodies vs. Councilman Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Mallory bodies</strong></td>\n<td><strong>Councilman bodies</strong></td>\n</tr>\n<tr>\n<td>Intra-cytoplasmic inclusions&nbsp;</td>\n<td>Acidophilic apoptotic bodies</td>\n</tr>\n<tr>\n<td>Due to aggregation of cytoskeletal intermediate filament</td>\n<td>&nbsp;Due to hepatocyte apoptosis&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 849\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Appears as clumped, amorphous, eosinophilic material within ballooned hepatocytes.</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Entire hepatocyte shrinks and appears as intense eosinophilic stained bodies</td>\n</tr>\n<tr>\n<td>\n<p>Seen in</p>\n<ul>\n<li>Alcoholic hepatitis</li>\n<li>Primary biliary cholangitis&nbsp;</li>\n<li>Alpha-1 antitrypsin deficiency</li>\n<li>Indian childhood cirrhosis</li>\n<li>Hepatocellular carcinoma&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>Seen in &nbsp;</p>\n<ul>\n<li>Acute viral hepatitis</li>\n<li>Yellow fever</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>Mallory bodies seen as clumped, amorphous eosinophilic material within ballooned hepatocytes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c3995e141b2f4a5fb51f696160da37e3x1280x1539.JPEG\" alt=\"Pearl Image\"><p>Councilman bodies where the entire cell is shrunken into intense eosinophilic apoptotic body</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db2e1403d1413ea08729154eb5cd37x1253x1026.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/54001e7258ee438d810295ecc11d15d0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2572",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following causes Laennec cirrhosis?",
      "choices": [
        {
          "id": 1,
          "text": "Alcohol"
        },
        {
          "id": 2,
          "text": "Hepatitis B"
        },
        {
          "id": 3,
          "text": "Hemochromatosis"
        },
        {
          "id": 4,
          "text": "Hepatitis C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Laennec cirrhosis </strong>is the classic micronodular cirrhosis seen in end-stage<strong> alcoholic liver disease.</strong></p>\n<div class=\"page\" title=\"Page 849\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>There are&nbsp;three&nbsp;distinctive, overlapping forms of alcoholic liver injury:</p>\n<ul>\n<li><strong>Hepatic steatosis (fatty liver)</strong><br />\n<ul>\n<li>Fatty change - completely reversible if there is abstention from further intake of alcohol</li>\n<li>Starts in centrilobular area</li>\n</ul>\n</li>\n<li><strong>Alcoholic (steato) hepatitis</strong>\n<ul>\n<li>Ballooning degeneration and necrosis</li>\n<li>Mallory&ndash;Denk bodies</li>\n<li>Neutrophilic reaction</li>\n</ul>\n</li>\n<li><strong>Alcoholic steatofibrosis</strong>\n<ul>\n<li>Perisinusoidal fibrosis and sclerosis of the central vein</li>\n<li>Diffuse nodularity of liver surface</li>\n<li>Micronodular/ Laennec cirrhosis</li>\n<li>Irreversible</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6096",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following histopathological findings will be seen in patients with chronic alcoholism?",
      "choices": [
        {
          "id": 1,
          "text": "Chicken-wire fence fibrosis"
        },
        {
          "id": 2,
          "text": "Rosette formation"
        },
        {
          "id": 3,
          "text": "Feathery degeneration of hepatocytes"
        },
        {
          "id": 4,
          "text": "Ground glass hepatocytes"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Chicken-wire fence </strong>pattern of fibrosis is seen in<strong>&nbsp;</strong>the liver biopsy of&nbsp;patients with <strong>alcoholic steatohepatitis</strong>. This pattern is due to <strong>perisinusoidal </strong>fibrosis encircling small clusters of hepatocytes.&nbsp;</p>\n<p>Trichrome staining of liver biopsy specimen showing perisinusoidal fibrosis (stained blue) in characteristic chicken-wire fence pattern is given below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/646efb06f339493598e98de853e2674fx1280x1052.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/72ad6ef5298e41e49dd38d61d16e4504x1280x1052.JPEG\" alt=\"Explanation Image\"><p>Note: Other conditions with chicken-wire pattern in histopathology:</p>\n<ul>\n<li>Chicken wire calcification - chondroblastoma</li>\n<li>Chicken wire vasculature - oligodendroglioma and myxoid liposarcoma</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6093",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following conditions does not result in micronodular cirrhosis?",
      "choices": [
        {
          "id": 1,
          "text": "Alcoholic cirrhosis"
        },
        {
          "id": 2,
          "text": "Viral hepatitis"
        },
        {
          "id": 3,
          "text": "Budd-Chiari syndrome"
        },
        {
          "id": 4,
          "text": "Hemochromatosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Viral hepatitis</strong> is associated with <strong>macronodular cirrhosis.</strong></p>\n<p><strong>Cirrhosis</strong> is comprised of <strong>regenerating parenchymal nodules</strong> surrounded by dense bands of the scar and variable degrees of vascular shunting. It is of two types:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Macronodular cirrhosis</strong></td>\n<td><strong>Micronodular cirrhosis</strong></td>\n</tr>\n<tr>\n<td><strong>Irregular</strong> nodules with variation in<strong>&nbsp;</strong>size<strong> &gt;3 mm</strong></td>\n<td><strong>Uniform</strong> nodules of size<strong> &lt;3 mm</strong></td>\n</tr>\n<tr>\n<td>\n<p>Causes:</p>\n<ul>\n<li>Chronic <strong>viral hepatitis</strong></li>\n<li>Wilsons disease</li>\n<li>&alpha;1-antitrypsin deficiency</li>\n<li>Drugs and toxins</li>\n<li>Hereditary hemorrhagic telangiectasia</li>\n<li>Cryptogenic cirrhosis</li>\n</ul>\n</td>\n<td>\n<p>Causes:</p>\n<ul>\n<li><strong>Alcoholic cirrhosis</strong></li>\n<li>Primary biliary cirrhosis</li>\n<li><strong>Hepatic vein obstruction</strong></li>\n<li>Large bile duct obstruction</li>\n<li><strong>Hemochromatosis</strong></li>\n<li>Intestinal bypass</li>\n<li>Cystic fibrosis</li>\n<li>Indian childhood cirrhosis</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The images given below show gross and histopathological micronodular alcoholic cirrhosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62df63872efa474f8022280b6aa58e2fx626x498.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/49a5b54660df4f58933497b54b7d05b0x847x562.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6013",
      "difficulty": "medium"
    },
    {
      "text": "In patients with non-alcoholic steatohepatitis, which of the following features is not seen on liver biopsy?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatocyte ballooning"
        },
        {
          "id": 2,
          "text": "Portal fibrosis"
        },
        {
          "id": 3,
          "text": "Lymphoid follicles"
        },
        {
          "id": 4,
          "text": "Perisinusoidal inflammation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The presence of<strong> lymphoid follicles</strong> is not a feature on liver biopsy in patients with non-alcoholic steatohepatitis (NASH). It is a feature of <strong>chronic hepatitis C infection.</strong></p>\n<p>The<strong> histopathological</strong> features of<strong> NASH</strong> include:</p>\n<ul>\n<li><strong>Ballooning degeneration </strong>of hepatocytes</li>\n<li>Steatosis</li>\n<li><strong>Perisinusoidal inflammation</strong> and fibrosis</li>\n<li><strong>Portal fibrosis</strong></li>\n<li>Mallory-Denk bodies</li>\n<li>Mononuclear infiltrate</li>\n</ul>\n<p>NASH and alcoholic liver disease (ALD) have almost similar histopathological features. They can be differentiated as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>ALD</strong></td>\n<td><strong>NASH</strong></td>\n</tr>\n<tr>\n<td>Mallory-Denk bodies</td>\n<td>More prominent</td>\n<td>Less prominent</td>\n</tr>\n<tr>\n<td>Fibrosis</td>\n<td>Perivenular and perisinusoidal&gt;portal</td>\n<td>Portal fibrosis is more prominent</td>\n</tr>\n<tr>\n<td>Inflammation</td>\n<td>More pronounced</td>\n<td>Less pronounced</td>\n</tr>\n<tr>\n<td>Inflammatory cells</td>\n<td>Neutrophils&gt;macrophages</td>\n<td>Macrophages&gt;neutrophils</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6099",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common hepatotoxin causing acute liver failure?",
      "choices": [
        {
          "id": 1,
          "text": "Methotrexate"
        },
        {
          "id": 2,
          "text": "Aflatoxin"
        },
        {
          "id": 3,
          "text": "Alcohol"
        },
        {
          "id": 4,
          "text": "Acetaminophen"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common hepatotoxin causing <strong>acute liver failure</strong> is<strong> acetaminophen.</strong></p>\n<p>Acetaminophen itself is not toxic. The toxic metabolite produced by the cytochrome P-450 system in zone 3 hepatocytes causes <strong>hepatocellular necrosis.</strong></p>\n<p>The most common hepatotoxin causing <strong>chronic liver failure</strong> is <strong>alcohol.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2589",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following does not cause chronic infection?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatitis D"
        },
        {
          "id": 2,
          "text": "Hepatitis C"
        },
        {
          "id": 3,
          "text": "Hepatitis E"
        },
        {
          "id": 4,
          "text": "Hepatitis A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hepatitis A does not cause chronic infection. It is usually a benign, self-limited disease.&nbsp;</p>\n<p><strong>Hepatitis B, C,</strong> and<strong> D</strong> can cause <strong>chronic infection</strong>. <strong>Hepatitis E</strong> causes <strong>chronic infection</strong> only in <strong>immunocompromised</strong> individuals, not in immunocompetent.</p><hr><h3>Related Pearl: The Hepatitis Viruses</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HAV</td>\n<td>HBV</td>\n<td>HCV</td>\n<td>HDV</td>\n<td>HEV</td>\n</tr>\n<tr>\n<td>Specific name</td>\n<td>Hepatovirus A</td>\n<td>Hepatitis B virus</td>\n<td>Hepacivirus C</td>\n<td>Hepatitis D virus</td>\n<td>Orthohepevirus A</td>\n</tr>\n<tr>\n<td>Family</td>\n<td>Picornaviridae</td>\n<td>Hepadnaviridae</td>\n<td>Flaviviridae</td>\n<td>Kolmioviridae (genus deltavirus)</td>\n<td>Hepeviridae</td>\n</tr>\n<tr>\n<td>Envelope</td>\n<td>Non enveloped</td>\n<td>Enveloped</td>\n<td>Enveloped</td>\n<td>Envelope from HBV</td>\n<td>Quasi-enveloped</td>\n</tr>\n<tr>\n<td>Nuclear material</td>\n<td>ssRNA</td>\n<td>Partially dsDNA</td>\n<td>ssRNA</td>\n<td>Circular defective ssRNA</td>\n<td>ssRNA</td>\n</tr>\n<tr>\n<td>Antigens</td>\n<td>HAV Ag</td>\n<td>HBsAg, HBcAg, HBeAg, HBxAg</td>\n<td>HCV Ag</td>\n<td>HBsAg, HDAg</td>\n<td>HEV Ag</td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>Anti-HAV Ab</td>\n<td>Anti-HBs Ab, Anti-HBc Ab, Anti-HBe Ab</td>\n<td>Anti-HCV Ab</td>\n<td>Anti-HBs Ab, Anti-HDV Ab</td>\n<td>Anti-HEV Ab</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Anti-LKM 1</td>\n<td>Anti-LKM 3</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Routes of transmission</td>\n<td>Feco-oral, parenteral, sexual</td>\n<td>Perinatal, parenteral, sexual, percutaneous, direct mucosal contact</td>\n<td>Parenteral, perinatal, percutaneous, sexual</td>\n<td>Parenteral, sexual</td>\n<td>Feco-oral, zoonotic, vertical</td>\n</tr>\n<tr>\n<td>Incubation period</td>\n<td>30 days</td>\n<td>60 days</td>\n<td>50 days</td>\n<td>60 days</td>\n<td>40 days</td>\n</tr>\n<tr>\n<td>Chances of fulminant hepatic failure</td>\n<td>0.1%</td>\n<td>0.1 to 1%</td>\n<td>0.1%</td>\n<td>5% in coinfections and 20% in superinfections</td>\n<td>1-2% in adults and up to 25% in pregnant women</td>\n</tr>\n<tr>\n<td>Extrahepatic manifestations</td>\n<td>Rash, arthralgia</td>\n<td>Polyarteritis nodosa and membranous nephropathy</td>\n<td>Essential mixed cryoglobulinemia, MPGN, Metabolic syndrome</td>\n<td>&nbsp; &nbsp; &nbsp; -</td>\n<td>GBS, Bell&rsquo;s palsy, pancreatitis, &nbsp;and glomerulonephritis</td>\n</tr>\n<tr>\n<td>Resolution of acute infection</td>\n<td>2 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>3 months</td>\n</tr>\n<tr>\n<td>Progression to chronic infection</td>\n<td>No</td>\n<td>5-10%</td>\n<td>&gt;80%</td>\n<td>\n<p>10% of co-infections,</p>\n<p>90&ndash;100% of superinfections</p>\n</td>\n<td>\n<p>Only in immuno-compromised</p>\n</td>\n</tr>\n<tr>\n<td>HCC</td>\n<td>No</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n</tr>\n<tr>\n<td>Vaccine</td>\n<td>Available</td>\n<td>Available</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>HBV vaccine</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>\n</tr>\n<tr>\n<td>Therapy</td>\n<td>None</td>\n<td>Entecavir, tenofovir, pegIFN-ùõÇ</td>\n<td>Velpatasvir, sofosbuvir, ribavirin</td>\n<td>PegIFN-ùõÇ</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6023",
      "difficulty": "easy"
    },
    {
      "text": "There is an outbreak of hepatitis A infection in a college hostel. Which of the following is false about this infection?",
      "choices": [
        {
          "id": 1,
          "text": "It does not cause hepatocellular carcinoma"
        },
        {
          "id": 2,
          "text": "The incubation period is 2-6 weeks"
        },
        {
          "id": 3,
          "text": "Liver failure is not a complication"
        },
        {
          "id": 4,
          "text": "Case fatality rate is 0.1%"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hepatitis A virus </strong>(HAV) can cause<strong> acute hepatic failure</strong>&nbsp;in a few patients.<strong>&nbsp;</strong>However,&nbsp;it does not cause chronic hepatitis or a carrier state.</p>\n<p>HAV is a usually benign, self-limited disease, with an <strong>incubation period </strong>of<strong> 15- 50 days</strong> (2 - 6 weeks).<strong>&nbsp;</strong></p>\n<p>HAV is spread by&nbsp;feco-oral route and<strong>&nbsp;</strong>is shed in the stool for 2 to 3 weeks before and 1 week after the onset of jaundice. It can also spread by sexual route. Diagnosis is by the detection of serum IgM anti HAV.</p>\n<p>Since it does not progress to chronic infection, it does not cause hepatocellular carcinoma. The fatality rate associated with HAV is only about <strong>0.1-0.3%.</strong></p><hr><h3>Related Pearl: The Hepatitis Viruses</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HAV</td>\n<td>HBV</td>\n<td>HCV</td>\n<td>HDV</td>\n<td>HEV</td>\n</tr>\n<tr>\n<td>Specific name</td>\n<td>Hepatovirus A</td>\n<td>Hepatitis B virus</td>\n<td>Hepacivirus C</td>\n<td>Hepatitis D virus</td>\n<td>Orthohepevirus A</td>\n</tr>\n<tr>\n<td>Family</td>\n<td>Picornaviridae</td>\n<td>Hepadnaviridae</td>\n<td>Flaviviridae</td>\n<td>Kolmioviridae (genus deltavirus)</td>\n<td>Hepeviridae</td>\n</tr>\n<tr>\n<td>Envelope</td>\n<td>Non enveloped</td>\n<td>Enveloped</td>\n<td>Enveloped</td>\n<td>Envelope from HBV</td>\n<td>Quasi-enveloped</td>\n</tr>\n<tr>\n<td>Nuclear material</td>\n<td>ssRNA</td>\n<td>Partially dsDNA</td>\n<td>ssRNA</td>\n<td>Circular defective ssRNA</td>\n<td>ssRNA</td>\n</tr>\n<tr>\n<td>Antigens</td>\n<td>HAV Ag</td>\n<td>HBsAg, HBcAg, HBeAg, HBxAg</td>\n<td>HCV Ag</td>\n<td>HBsAg, HDAg</td>\n<td>HEV Ag</td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>Anti-HAV Ab</td>\n<td>Anti-HBs Ab, Anti-HBc Ab, Anti-HBe Ab</td>\n<td>Anti-HCV Ab</td>\n<td>Anti-HBs Ab, Anti-HDV Ab</td>\n<td>Anti-HEV Ab</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Anti-LKM 1</td>\n<td>Anti-LKM 3</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Routes of transmission</td>\n<td>Feco-oral, parenteral, sexual</td>\n<td>Perinatal, parenteral, sexual, percutaneous, direct mucosal contact</td>\n<td>Parenteral, perinatal, percutaneous, sexual</td>\n<td>Parenteral, sexual</td>\n<td>Feco-oral, zoonotic, vertical</td>\n</tr>\n<tr>\n<td>Incubation period</td>\n<td>30 days</td>\n<td>60 days</td>\n<td>50 days</td>\n<td>60 days</td>\n<td>40 days</td>\n</tr>\n<tr>\n<td>Chances of fulminant hepatic failure</td>\n<td>0.1%</td>\n<td>0.1 to 1%</td>\n<td>0.1%</td>\n<td>5% in coinfections and 20% in superinfections</td>\n<td>1-2% in adults and up to 25% in pregnant women</td>\n</tr>\n<tr>\n<td>Extrahepatic manifestations</td>\n<td>Rash, arthralgia</td>\n<td>Polyarteritis nodosa and membranous nephropathy</td>\n<td>Essential mixed cryoglobulinemia, MPGN, Metabolic syndrome</td>\n<td>&nbsp; &nbsp; &nbsp; -</td>\n<td>GBS, Bell&rsquo;s palsy, pancreatitis, &nbsp;and glomerulonephritis</td>\n</tr>\n<tr>\n<td>Resolution of acute infection</td>\n<td>2 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>3 months</td>\n</tr>\n<tr>\n<td>Progression to chronic infection</td>\n<td>No</td>\n<td>5-10%</td>\n<td>&gt;80%</td>\n<td>\n<p>10% of co-infections,</p>\n<p>90&ndash;100% of superinfections</p>\n</td>\n<td>\n<p>Only in immuno-compromised</p>\n</td>\n</tr>\n<tr>\n<td>HCC</td>\n<td>No</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n</tr>\n<tr>\n<td>Vaccine</td>\n<td>Available</td>\n<td>Available</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>HBV vaccine</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>\n</tr>\n<tr>\n<td>Therapy</td>\n<td>None</td>\n<td>Entecavir, tenofovir, pegIFN-ùõÇ</td>\n<td>Velpatasvir, sofosbuvir, ribavirin</td>\n<td>PegIFN-ùõÇ</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6024",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is the most common cause of sporadic acute hepatitis in India?",
      "choices": [
        {
          "id": 1,
          "text": "HAV"
        },
        {
          "id": 2,
          "text": "HBV"
        },
        {
          "id": 3,
          "text": "HCV"
        },
        {
          "id": 4,
          "text": "HEV"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hepatitis E virus (<strong>HEV</strong>) infection accounts for most&nbsp;of the cases of<strong> sporadic acute hepatitis </strong>in<strong> India</strong>. It&nbsp;exceeds the frequency of hepatitis A virus infection.</p>\n<p>A feature of HEV infection is the<strong> high mortality </strong>rate among<strong> pregnant women</strong>, approaching 20%.</p><hr><h3>Related Pearl: The most commons in hepatitis</h3><table>\n<tbody>\n<tr>\n<td><strong>CAUSE</strong></td>\n<td><strong>ETIOLOGICAL AGENT</strong></td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatitis</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in children</td>\n<td>HepA</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in adults</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common¬†cause of viral hepatitis in pregnancy</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis related mortality in pregnancy</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure (Western countries)</td>\n<td>Paracetamol poisoning</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure in India</td>\n<td>¬†Viral hepatitis (B and E)</td>\n</tr>\n<tr>\n<td>Most common cause of viral fulminant hepatitis</td>\n<td>¬†HepE</td>\n</tr>\n<tr>\n<td>Highest risk of progresion from acute viral hepatitis to fulminant hepatitis</td>\n<td>HepD¬†</td>\n</tr>\n<tr>\n<td>Most common cause of chronic hepatitis (prevalence)</td>\n<td>HepB (450 million)</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis, leading to chronic<br />hepatitis (prevalence)</td>\n<td>¬†HepC (150 million)</td>\n</tr>\n<tr>\n<td>Maximum risk and max potential of chronicity</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of carrier State</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of cirrhosis</td>\n<td>Alcohol</td>\n</tr>\n<tr>\n<td>Most common viral cause of cirrhosis</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatocellular carcinoma</td>\n<td>HepB</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6064",
      "difficulty": "hard"
    },
    {
      "text": "A 53-year-old man who has a history of chronic hepatitis B is diagnosed to have hepatocellular carcinoma. Which of the following is involved in the pathogenesis of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "HBs Ag"
        },
        {
          "id": 2,
          "text": "HBe Ag"
        },
        {
          "id": 3,
          "text": "HBV DNA polymerase"
        },
        {
          "id": 4,
          "text": "HBx protein"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>HBx protein</strong>&nbsp;has been implicated in the pathogenesis of <strong>hepatocellular carcinoma</strong> in <strong>hepatitis B</strong> virus (HBV) infection. HBx protein is involved in the intracellular regulation of&nbsp;virus replication,<strong>&nbsp;</strong>transcription, and signal transduction.</p>\n<p>Option A: HBsAg (surface antigen) indicates current hepatitis B infection.</p>\n<p>Option B: HBeAg (precore antigen) is an indicator of active viral replication. It is a qualitative marker of infectivity.</p>\n<p>Option C: HBV DNA polymerase is an indicator of active viral replication. It is a quantitative marker of infectivity.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6028",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following serological markers can be used to diagnose hepatitis B infection during the window period?",
      "choices": [
        {
          "id": 1,
          "text": "HBs Ag"
        },
        {
          "id": 2,
          "text": "Anti-HBs Ab IgM"
        },
        {
          "id": 3,
          "text": "Anti-HBc Ab IgM"
        },
        {
          "id": 4,
          "text": "HBe Ag"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>During the <strong>window period</strong> of hepatitis B, the serologic diagnosis can be made by the detection of <strong>IgM anti-HBc antibody.</strong></p>\n<p>The window period of hepatitis B refers to the time <strong>between</strong> the <strong>disappearance</strong> of the <strong>HBsAg</strong> antigen and <strong>appearance</strong> of <strong>Anti-HBs</strong> antibody.</p>\n<p>The window period for a test designed to detect a specific disease is the time between the first infection and when the test can reliably detect that infection.</p><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6036",
      "difficulty": "medium"
    },
    {
      "text": "In a patient who is both HBsAg and HBeAg positive, what does declining IgM anti-HBc and rising total anti-HBc indicate?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic  non-infective hepatitis"
        },
        {
          "id": 2,
          "text": "Chronic  infective hepatitis"
        },
        {
          "id": 3,
          "text": "Acute non-infective hepatitis"
        },
        {
          "id": 4,
          "text": "Acute fulminant hepatitis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In patients who are both¬†HBsAg and HBeAg positive,¬†<strong>declining</strong> <strong>IgM</strong> anti-HBc and <strong>rising</strong> <strong>total</strong> anti-HBc are indicative of¬†<strong>chronic infective hepatitis</strong>.</p>\n<p><strong>Anti-HBc IgM</strong> antibody signifies <strong>acute infection</strong>/<strong>window period</strong>, whereas, the presence of <strong>IgG anti-HBc</strong>¬†indicates <strong>chronic infection</strong>. However, there is no test available to directly detect the IgG anti-HBC. Over a period of months, the IgM anti-HBc antibodies are replaced by the IgG anti-HBc antibodies. Thus a decline of IgM antibodies in the presence of rising total anti-HBC indicates that the IgM is being converted to IgG and thus the infection is chronic.¬†¬†</p>\n<p><strong>HBeAg</strong>, HBV-DNA, and DNA polymerase appear in serum soon after HBsAg, and all signify <strong>active viral replication.</strong></p>\n<p>Occasionally, mutated strains of HBV emerge that do not produce HBeAg but are replication-competent and express HBcAg.</p><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2810",
      "difficulty": "easy"
    },
    {
      "text": "A patient with a history of unprotected sexual intercourse turns out to be HBsAg positive. Which of the following is the best predictor for development of chronic disease?",
      "choices": [
        {
          "id": 1,
          "text": "Age"
        },
        {
          "id": 2,
          "text": "Viral load"
        },
        {
          "id": 3,
          "text": "Immune status"
        },
        {
          "id": 4,
          "text": "Pre-existing liver diseases"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>age </strong>at the time of infection is the <strong>best predictor </strong>of <strong>chronicity.¬†</strong>Younger the age at the time of hepatitis B virus (HBV) infection, higher the probability of chronicity.</p>\n<p>Other predictors in the development of chronic disease:</p>\n<ul>\n<li>comorbid conditions (including exposure to other infectious agents)</li>\n<li>host immunity</li>\n</ul>\n<p>Presentations of hepatitis B infection:</p>\n<ul>\n<li>Asymptomatic - 65%</li>\n<li>Non-specific symptoms - 25%</li>\n<li>Chronic disease - 5-10%</li>\n<li>Acute fulminant liver disease - 0.1-0.5%</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6037",
      "difficulty": "hard"
    },
    {
      "text": "An IV drug abuser has been found to be seropositive for HBsAg, HBeAg, and anti-HBc IgM. Which of the following is least likely to be seen in the liver biopsy of such patients?",
      "choices": [
        {
          "id": 1,
          "text": "Ballooning degeneration"
        },
        {
          "id": 2,
          "text": "Ground glass hepatocytes"
        },
        {
          "id": 3,
          "text": "Focal or spotty necrosis"
        },
        {
          "id": 4,
          "text": "Confluent necrosis of hepatocytes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>acute hepatitis B </strong>infection. Ground-glass hepatocytes are not seen in the liver biopsy of such patients.</p>\n<p><strong>Histopathological</strong> findings in acute hepatits are:</p>\n<ul>\n<li>Ballooning degeneration - due to inflammation</li>\n<li>Portal or lobular inflammatory infiltration - lymphocytes, plasma cells, and eosinophils</li>\n<li>Necrosis\n<ul>\n<li>Confluent necrosis - group of hepatocytes</li>\n<li>Panlobular or panacinar necrosis - entire lobule</li>\n<li>Bridging necrosis (in severe cases) - connecting vascular structures</li>\n</ul>\n</li>\n</ul>\n<p><strong>Ground-glass appearance</strong> of hepatocytes is due to the¬†endoplasmic reticulum which is swollen with HBsAg accumulation. It is a diagnostic hallmark of<strong>¬†chronic hepatitis B</strong> infection.</p>\n<p>The image given below shows ground glass hepatocytes in the liver biopsy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05a515e78673492e87a60172771f87fdx1280x1157.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a7bf9255aab24a4681e0f054eaef5bdfx1280x1157.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Acute Hepatitis vs. Chronic Hepatitis</h3><table>\n<tbody>\n<tr>\n<td><strong>Histological features of acute hepatitis</strong></td>\n<td><strong>Histological features of chronic hepatitis</strong></td>\n</tr>\n<tr>\n<td>Ballooning degeneration</td>\n<td>Ductular reaction</td>\n</tr>\n<tr>\n<td>Apoptosis of hepatocytes - <strong>Councilman bodies¬†</strong></td>\n<td>Bridging fibrosis¬†</td>\n</tr>\n<tr>\n<td>Confluent necrosis</td>\n<td>Bridging necrosis</td>\n</tr>\n<tr>\n<td>Spotty necrosis or lobular<strong> hepatitis¬†</strong></td>\n<td>Interface hepatitis¬†</td>\n</tr>\n<tr>\n<td>Bridging necrosis in severe acute hepatitis</td>\n<td>Dense, mononuclear portal infiltration¬†</td>\n</tr>\n<tr>\n<td>Portal inflammation is absent¬†</td>\n<td><strong>Chronic viral hepatitis</strong></td>\n</tr>\n<tr>\n<td>¬†</td>\n<td>Ground glass hepatocytes¬†</td>\n</tr>\n<tr>\n<td>¬†</td>\n<td>Lymphoid aggregates or fully formed lymphoid follicles</td>\n</tr>\n<tr>\n<td>¬†</td>\n<td>Fatty change of scattered hepatocytes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed3b8d201aea404fbad0181756978b57x1280x3480.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6019",
      "difficulty": "medium"
    },
    {
      "text": "A man with a history of intranasal cocaine abuse is at most risk for which of the following infections?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatitis E"
        },
        {
          "id": 2,
          "text": "Hepatitis B"
        },
        {
          "id": 3,
          "text": "Hepatitis C"
        },
        {
          "id": 4,
          "text": "Hepatitis A"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Intranasal cocaine</strong>&nbsp;abuse is a risk factor for <strong>hepatitis C.</strong></p>\n<p><strong>Contaminated implements </strong>(like straws used to inhale cocaine)&nbsp;inserted into the nasal cavity might come into contact with hepatitis C virus (HCV)-infected mucus or blood. This might then be transmitted to a susceptible individual while sharing the same implements.</p>\n<div class=\"page\" title=\"Page 839\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Transmission</strong> of hepatitis C infection:&nbsp;</p>\n<ul>\n<li><strong>Intravenous drug abuse (54%) - Most common</strong></li>\n<li>Multiple sex partners</li>\n<li>Needle-stick injury</li>\n<li>Multiple contacts with a person with hepatitis C virus infection</li>\n<li>Employment in medical or dental fields</li>\n<li>Blood transfusion</li>\n<li><strong>Perinatal</strong> - major route of infection in <strong>children</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6066",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common clinical course in patients diagnosed with hepatitis C infection?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic carrier state"
        },
        {
          "id": 2,
          "text": "Cirrhosis"
        },
        {
          "id": 3,
          "text": "Hepatic decompensation"
        },
        {
          "id": 4,
          "text": "Hepatocellular carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The&nbsp;<strong>most common </strong>clinical course seen in<strong> hepatitis C </strong>infection is<strong> chronic carrier state</strong>.</p>\n<p>Acute clinical illness is often asymptomatic/mild with a high rate of conversion to chronic hepatitis (~85%).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e443f01d160c46ac87f5666402de9489x1280x1059.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6043",
      "difficulty": "medium"
    },
    {
      "text": "Which genotype of hepatitis C virus is associated with metabolic syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "4"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hepatitis C</strong> virus (HCV)<strong> genotype 3</strong>&nbsp;is associated with<strong>&nbsp;metabolic syndrome.</strong></p>\n<p>HCV can give rise to <strong>insulin resistance</strong> and non-alcoholic fatty liver disease (<strong>NAFLD</strong>).</p><hr><h3>Related Pearl: Extrahepatic Manifestations of Hepatitis B and C</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Hepatitis B</strong></td>\n<td><strong>Hepatitis C</strong></td>\n</tr>\n<tr>\n<td>Hematological</td>\n<td>\n<p>Aplastic anemia</p>\n</td>\n<td>\n<p>Essential mixed cryoglobulinemia</p>\n</td>\n</tr>\n<tr>\n<td>Renal</td>\n<td>\n<p>Membranous glomerulonephritis (hepatitis B &gt; C)</p>\n<p>Membranoproliferative glomerulonephritis</p>\n</td>\n<td>\n<p>Membranoproliferative glomerulonephritis</p>\n<p>Membranous glomerulonephritis &nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Vascular</td>\n<td>\n<p>Polyarteritis nodosa (hepatitis B&gt;C)</p>\n</td>\n<td>\n<p>Leukocytoclastic vasculitis</p>\n</td>\n</tr>\n<tr>\n<td>Dermatologic</td>\n<td>\n<p>Erythema multiforme (Hepatitis B&gt;C)</p>\n<p>Urticaria</p>\n<p>Serum sickness</p>\n<p>Infantile papular acrodermatitis (Gianotti&ndash;Crosti syndrome)</p>\n<p>Erythema nodosum</p>\n</td>\n<td>\n<p>Erythema multiforme</p>\n<p>Sporadic porphyria cutanea tarda</p>\n<p>Lichen planus</p>\n<p>Necrolytic acral erythema</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Hepatitis C also increases the risk of:</p>\n<ul>\n<li>Non-Hodgkin&rsquo;s lymphoma</li>\n<li>Idiopathic thrombocytopenic purpura</li>\n<li>Autoimmune hemolytic anemia</li>\n<li>Diabetes mellitus</li>\n<li>Autoimmune thyroiditis &nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6045",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old male patient with chronic hepatitis B infection comes for a follow-up visit. Which of the following is not a histopathological feature of the liver in such cases?",
      "choices": [
        {
          "id": 1,
          "text": "Bridging necrosis and fibrosis"
        },
        {
          "id": 2,
          "text": "Ground-glass hepatocytes"
        },
        {
          "id": 3,
          "text": "Ballooning  degeneration"
        },
        {
          "id": 4,
          "text": "Piecemeal necrosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Ballooning degeneration</strong> is not¬†associated with chronic hepatitis. It is seen in <strong>acute hepatitis</strong>.</p>\n<p>Histopathological findings in chronic viral hepatitis are:</p>\n<ul>\n<li>Portal lymphocytic/ lymphoplasmacytic inflammation</li>\n<li>Interface activity - inflammatory cells cross the limiting plate and cause periportal hepatocyte injury</li>\n<li>Portal, periportal, and portoportal bridging fibrosis</li>\n</ul>\n<p>Specific findings in viral hepatitis:</p>\n<ul>\n<li>Hepatitis B - ground glass hepatocytes</li>\n<li>Hepatitis C - lymphoid aggregates and steatosis</li>\n</ul><hr><h3>Related Pearl: Acute Hepatitis vs. Chronic Hepatitis</h3><table>\n<tbody>\n<tr>\n<td><strong>Histological features of acute hepatitis</strong></td>\n<td><strong>Histological features of chronic hepatitis</strong></td>\n</tr>\n<tr>\n<td>Ballooning degeneration</td>\n<td>Ductular reaction</td>\n</tr>\n<tr>\n<td>Apoptosis of hepatocytes - <strong>Councilman bodies¬†</strong></td>\n<td>Bridging fibrosis¬†</td>\n</tr>\n<tr>\n<td>Confluent necrosis</td>\n<td>Bridging necrosis</td>\n</tr>\n<tr>\n<td>Spotty necrosis or lobular<strong> hepatitis¬†</strong></td>\n<td>Interface hepatitis¬†</td>\n</tr>\n<tr>\n<td>Bridging necrosis in severe acute hepatitis</td>\n<td>Dense, mononuclear portal infiltration¬†</td>\n</tr>\n<tr>\n<td>Portal inflammation is absent¬†</td>\n<td><strong>Chronic viral hepatitis</strong></td>\n</tr>\n<tr>\n<td>¬†</td>\n<td>Ground glass hepatocytes¬†</td>\n</tr>\n<tr>\n<td>¬†</td>\n<td>Lymphoid aggregates or fully formed lymphoid follicles</td>\n</tr>\n<tr>\n<td>¬†</td>\n<td>Fatty change of scattered hepatocytes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed3b8d201aea404fbad0181756978b57x1280x3480.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2581",
      "difficulty": "medium"
    },
    {
      "text": "In patients with liver failure, which of the following tests is not used to evaluate the synthetic function of hepatocytes?",
      "choices": [
        {
          "id": 1,
          "text": "Serum ammonia"
        },
        {
          "id": 2,
          "text": "APTT"
        },
        {
          "id": 3,
          "text": "Serum albumin"
        },
        {
          "id": 4,
          "text": "Serum alkaline phosphatase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Serum alkaline phosphatase </strong>is used to evaluate<strong> biliary excretory function.&nbsp;</strong>It is not used to evaluate the synthetic function of hepatocytes.</p>\n<p>Serum ammonia, activated partial thromboplastin time (aPTT), and serum albumin are used to evaluate hepatic synthetic function.</p>\n<p>Prothrombin time (PT), aPTT and serum ammonia levels are increased in liver failure, whereas serum albumin level is decreased.</p><hr><h3>Related Pearl: Laboratory Evaluation of Liver Disease</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Test Category</strong></p>\n</td>\n<td>\n<p><strong>Serum measurement</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte integrity</p>\n</td>\n<td>\n<p><strong>Cytosolic hepatocellular enzymes</strong></p>\n<p>Serum aspartate aminotransferase (AST)</p>\n<p>Serum alanine aminotransferase (ALT)</p>\n<p>Serum lactate dehydrogenase (LDH)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biliary excretory function</p>\n</td>\n<td>\n<p><strong>Substances normally secreted in bile</strong></p>\n<p>Serum bilirubin</p>\n<ul>\n<li>Total: unconjugated plus conjugated</li>\n<li>Direct: conjugated only</li>\n</ul>\n<p>Urine bilirubin</p>\n<p>Serum bile acids</p>\n<p><strong>Plasma membrane enzymes (from damage to bile canaliculus)</strong></p>\n<p>Serum alkaline phosphatase</p>\n<p>Serum &gamma;-glutamyl transpeptidase (GGT)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte synthetic function</p>\n</td>\n<td>\n<p><strong>Proteins secreted into the blood</strong></p>\n<p>Serum albumin</p>\n<p>Coagulation factors:</p>\n<p>Prothrombin (PT) and partial thromboplastin time (PTT) (fibrinogen, prothrombin, factors V, VII, IX, and X)</p>\n<p><strong>Hepatocyte metabolism</strong></p>\n<p>Serum ammonia</p>\n<p>Aminopyrine breath test (hepatic demethylation)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5979",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not seen in the histopathological examination of the liver in patients with malaria?",
      "choices": [
        {
          "id": 1,
          "text": "Mononuclear portal infiltrate"
        },
        {
          "id": 2,
          "text": "Macronodular cirrhosis"
        },
        {
          "id": 3,
          "text": "Hemozoin pigment deposition"
        },
        {
          "id": 4,
          "text": "Fatty change and periportal inflammation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Macronodular cirrhosis is not seen in the histopathological examination of patients with malaria.</p>\n<p><strong>Histopathological</strong> changes in the liver in cases of<strong> malaria</strong> include the following:</p>\n<ul>\n<li>Kupffer cell hyperplasia</li>\n<li><strong>Hemozoin pigment deposition</strong> within Kupffer cells and macrophages</li>\n<li><strong>Focal necrosis</strong></li>\n<li>Mild mononuclear portal infiltrate</li>\n<li><strong>Fatty change </strong>and<strong> periportal inflammation</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6068",
      "difficulty": "medium"
    },
    {
      "text": "Identify the incorrect match.",
      "choices": [
        {
          "id": 1,
          "text": "Mallory-Denk bodies‚ÄîAlcoholic liver disease"
        },
        {
          "id": 2,
          "text": "Councilman bodies‚ÄîChronic hepatitis"
        },
        {
          "id": 3,
          "text": "Ground glass hepatocytes‚ÄîHepatitis B"
        },
        {
          "id": 4,
          "text": "Onion skin fibrosis‚ÄîPrimary sclerosing cholangitis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Councilman bodies</strong> are apoptotic hepatocytes seen in<strong> acute hepatitis </strong>and<strong> yellow fever.</strong></p>\n<p>Option A: <strong>Mallory&ndash;Denk bodies</strong> are eosinophilic materials made of keratin intermediate filaments. They are seen in <strong>alcoholic liver disease, </strong>non-alcoholic fatty liver disease, Wilson's disease,&nbsp;and chronic biliary tract diseases.</p>\n<p>Option C:<strong> Ground-glass hepatocytes</strong>&nbsp;are liver cells that have eosinophilic granular, glassy cytoplasm seen on light microscopy. The appearance is due to the&nbsp;<strong>swelling of the</strong>&nbsp;<strong>endoplasmic reticulum by HBsAg </strong>and is a diagnostic hallmark of chronic hepatitis B.</p>\n<p>Option D:<strong> Circumferential onion skin fibrosis </strong>around a degenerating bile-duct lumen is seen in<strong>&nbsp;primary sclerosing cholangitis</strong>.</p><hr><h3>Related Pearl: Mallory Bodies vs. Councilman Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Mallory bodies</strong></td>\n<td><strong>Councilman bodies</strong></td>\n</tr>\n<tr>\n<td>Intra-cytoplasmic inclusions&nbsp;</td>\n<td>Acidophilic apoptotic bodies</td>\n</tr>\n<tr>\n<td>Due to aggregation of cytoskeletal intermediate filament</td>\n<td>&nbsp;Due to hepatocyte apoptosis&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 849\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Appears as clumped, amorphous, eosinophilic material within ballooned hepatocytes.</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Entire hepatocyte shrinks and appears as intense eosinophilic stained bodies</td>\n</tr>\n<tr>\n<td>\n<p>Seen in</p>\n<ul>\n<li>Alcoholic hepatitis</li>\n<li>Primary biliary cholangitis&nbsp;</li>\n<li>Alpha-1 antitrypsin deficiency</li>\n<li>Indian childhood cirrhosis</li>\n<li>Hepatocellular carcinoma&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>Seen in &nbsp;</p>\n<ul>\n<li>Acute viral hepatitis</li>\n<li>Yellow fever</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>Mallory bodies seen as clumped, amorphous eosinophilic material within ballooned hepatocytes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c3995e141b2f4a5fb51f696160da37e3x1280x1539.JPEG\" alt=\"Pearl Image\"><p>Councilman bodies where the entire cell is shrunken into intense eosinophilic apoptotic body</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db2e1403d1413ea08729154eb5cd37x1253x1026.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9182",
      "difficulty": "easy"
    },
    {
      "text": "A patient with ascites, melena, and splenomegaly is diagnosed with portal hypertension. Which of the following is not an intrahepatic cause of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Non-alcoholic fatty liver disease"
        },
        {
          "id": 2,
          "text": "Amyloidosis"
        },
        {
          "id": 3,
          "text": "Schistosomiasis"
        },
        {
          "id": 4,
          "text": "Obstructive thrombosis of portal vein"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Obstructive portal vein thrombosis</strong> is the <strong>prehepatic cause</strong> of portal hypertension.</p>\n<p>Non-alcoholic fatty liver disease, cirrhosis, and schistosomiasis are intrahepatic causes of<strong> portal hypertension</strong>. The most dominant cause is <strong>cirrhosis</strong>.</p><hr><h3>Related Pearl: Causes of Portal Hypertension</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ba11a261470c410298f73941ff987a2fx1280x2190.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5990",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a feature of liver histology in patients with non-cirrhotic portal fibrosis?",
      "choices": [
        {
          "id": 1,
          "text": "Sinusoidal dilatation"
        },
        {
          "id": 2,
          "text": "Thrombosis of the medium and small portal vein branches"
        },
        {
          "id": 3,
          "text": "Micronodular transformation"
        },
        {
          "id": 4,
          "text": "Bridging fibrosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Bridging fibrosis is not seen in <strong>non-cirrhotic portal fibrosis.</strong>&nbsp;In this condition, there is&nbsp;<strong>periportal </strong>and <strong>perisinusoidal fibrosis. </strong>The fibrous septa end blindly in the lobule and<strong> do not bridge </strong>with other portal tracts, unlike those seen in cirrhosis.</p>\n<p>Idiopathic non-cirrhotic portal hypertension (<strong>INCPH</strong>) is a rare disease characterized by intrahepatic portal hypertension in the absence of cirrhosis or other causes of liver disease and<strong> s</strong>planchnic venous thrombosis.</p>\n<p>A<strong> liver biopsy</strong> is essential in making a diagnosis of INCPH.&nbsp;The features observed are as follows:</p>\n<ul>\n<li>Luminal narrowing or <strong>obliteration of portal vein</strong> branches</li>\n<li><strong>Micronodular transformation</strong></li>\n<li><strong>Sinusoidal dilatation</strong> with formation of mega sinusoids</li>\n<li>Periportal and perisinusoidal fibrosis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5993",
      "difficulty": "medium"
    },
    {
      "text": "Match the histopathological sections of liver and the different conditions.",
      "choices": [
        {
          "id": 1,
          "text": "1-Alcoholic steatosis, 2-Alcoholic hepatitis, 3-micronodular cirrhosis, 4-Portal fibrosis"
        },
        {
          "id": 2,
          "text": "1-Macronodular cirrhosis, 2-Micronodular cirrhosis, 3-Alcoholic steatosis, 4-Alcoholic hepatitis"
        },
        {
          "id": 3,
          "text": "1-Normal liver, 2-Alcoholic steatosis, 3- Micronodular cirrhosis, 4-Alcoholic hepatitis"
        },
        {
          "id": 4,
          "text": "1-Normal liver, 2-Alcoholic hepatitis, 3-Macronodular cirrhosis, 4-Alcoholic steatosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given image, images marked 1 is normal liver, 2 is alcoholic steatosis, 3 is micronodular cirrhosis and 4 is alcoholic hepatitis.</p>\n<p>Histopathological findings in the following conditions are:</p>\n<ul>\n<li><strong>Alcoholic steatosis</strong>:\n<ul>\n<li>A mix of small and large fat droplets</li>\n<li>Ethanol inhibits fatty acid metabolism, leading to lipolysis and increased triglyceride. These triglycerides accumulate and cause steatosis. Liver enzymes are normal at this stage.</li>\n</ul>\n</li>\n<li><strong>Micronodular cirrhosis</strong>:\n<ul>\n<li>The average nodule size is 3 mm in this close-up view, which is typical of the micronodular cirrhosis of alcoholic liver disease</li>\n</ul>\n</li>\n<li><strong>Alcoholic hepatitis</strong>:\n<ul>\n<li>Mallory-Denk bodies - clumped, amorphous, eosinophilic material in ballooned hepatocytes. These inclusions are characteristic, but not a specific feature of alcoholic liver disease.</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3900fb29736a4dc5bc2a0940ce73341cx1280x1293.JPEG\" alt=\"Explanation Image\"><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sunday, 28 July-World Hepatitis Day 2019\\nWorld liver day is observed on the 19th of APril, to spread awareness about liver disorders.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">World liver day is observed on the 19th of April, to spread awareness about the liver, the role it plays in our body and liver-related diseases.&nbsp;</span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Sunday, 28 July-World Hepatitis Day 2019\\nWorld liver day is observed on the 19th of APril, to spread awareness about liver disorders.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}\">World Hepatitis Day, observed on July 28 every year, aims to raise global awareness of hepatitis.</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cbc6645de5cf4bada9373467fbfc956a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6469",
      "difficulty": "medium"
    },
    {
      "text": "Match the following:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Liver findings</strong></td>\n</tr>\n<tr>\n<td>1. Valproate</td>\n<td>A.&nbsp;Mallory-Denk bodies</td>\n</tr>\n<tr>\n<td>2. Allopurinol</td>\n<td>B.&nbsp;Microvesicular steatosis</td>\n</tr>\n<tr>\n<td>3. Amiodarone</td>\n<td>C.&nbsp;Noncaseating epitheloid granuloma</td>\n</tr>\n<tr>\n<td>4. Isoniazid</td>\n<td>D.&nbsp;Fibrin ring granuloma</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-C, 2-D, 3-A, 4-B"
        },
        {
          "id": 2,
          "text": "1-B, 2-D, 3-A, 4-C"
        },
        {
          "id": 3,
          "text": "1-D, 2-A, 3-B, 4-C"
        },
        {
          "id": 4,
          "text": "1-B, 2-A, 3-D, 4-C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The liver findings seen in the hepatotoxic drugs are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Liver findings</strong></td>\n</tr>\n<tr>\n<td>Valproate</td>\n<td>Microvesicular steatosis</td>\n</tr>\n<tr>\n<td>Allopurinol</td>\n<td>Fibrin ring granuloma</td>\n</tr>\n<tr>\n<td>Amiodarone</td>\n<td>Mallory-Denk bodies</td>\n</tr>\n<tr>\n<td>Isoniazid</td>\n<td>Noncaseating epitheloid granulomas</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7000",
      "difficulty": "medium"
    }
  ]
}